EICHORCondition: Restless Legs Syndrome · Sponsor: Noctrix Health, Inc.
Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Mark J Buchfuhrer, MD Office | Downey, California, United States | — |
| Sleep Medicine Specialists of California | San Ramon, California, United States | — |
| Neurocare, Inc. | Newton, Massachusetts, United States | — |
| Clayton Sleep Institute | St Louis, Missouri, United States | — |
| Ohio Sleep Medicine and Institute | Dublin, Ohio, United States | — |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | — |
| Bogan Sleep Consultants, LLC | Columbia, South Carolina, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06076499